October 12: The Nations

Sennacherib king of Assyria came and entered Judah; encamping against the fortified cities. Hoping to prevent military action, he attempted to instill fear in the hearts of the people, much like Israel’s enemies today.

2 Chronicles 32:16-23

Furthermore, his servants spoke against the Lord God and against His servant Hezekiah.

He also wrote letters to revile the Lord God of Israel, and to speak against Him, saying, “As the gods of the nations of other lands have not delivered their people from my hand, so the God of Hezekiah will not deliver His people from my hand.”  Then they called out with a loud voice in Hebrew to the people of Jerusalem who were on the wall, to frighten them and trouble them, that they might take the city.  And they spoke against the God of Jerusalem, as against the gods of the people of the earth—the work of men’s hands.

 Now because of this King Hezekiah and the prophet Isaiah, the son of Amoz, prayed and cried out to heaven.  Then the Lord sent an angel who cut down every mighty man of valor, leader, and captain in the camp of the king of Assyria. So he returned shamefaced to his own land. And when he had gone into the temple of his god, some of his own offspring struck him down with the sword there.

 Thus the Lord saved Hezekiah and the inhabitants of Jerusalem from the hand of Sennacherib the king of Assyria, and from the hand of all others, and [gave them rest] on every side.  And many brought gifts to the Lord at Jerusalem, and presents to Hezekiah king of Judah, so that he was exalted in the sight of all nations thereafter.

PRAY ISRAEL WILL NOT FEAR THE ENEMY, BUT ONLY FEAR HER LORD GOD.

 The Superbug kits are based on a novel method that was developed by Professor Emeritus Nathan Citri, from the Faculty of Medicine, The Hebrew University of Jerusalem. It enables direct and precise recognition of bacterial resistance to all members of the family of beta-lactams, which is the most widely used group of antibiotics, including penicillins, cephalosporins and carbapenems. Furthermore, the kits not only detect the presence of bacteria resistant to antibiotics, but also offer immediate information on the type of antibiotic that may still be of use. “We are pleased to collaborate with BioConnections for the commercialization of this invention” Ken Denton, CEO of BioConnections, said, "We are very excited with this new partnership, and are convinced that Prof. Citri's invention will improve patient care, saving lives, shortening hospital stays and significantly reducing health care costs. The first kits are in the last stages of development, and we hope it will reach the market within months. In parallel, we have applied for a CE mark for marketing of the kits in Europe."
The Superbug kits are based on a novel method that was developed by Professor Emeritus Nathan Citri, from the Faculty of Medicine, The Hebrew University of Jerusalem. It enables direct and precise recognition of bacterial resistance to all members of the family of beta-lactams, which is the most widely used group of antibiotics, including penicillins, cephalosporins and carbapenems. Furthermore, the kits not only detect the presence of bacteria resistant to antibiotics, but also offer immediate information on the type of antibiotic that may still be of use.
“We are pleased to collaborate with BioConnections for the commercialization of this invention”
Ken Denton, CEO of BioConnections, said, “We are very excited with this new partnership, and are convinced that Prof. Citri’s invention will improve patient care, saving lives, shortening hospital stays and significantly reducing health care costs. The first kits are in the last stages of development, and we hope it will reach the market within months. In parallel, we have applied for a CE mark for marketing of the kits in Europe.”

Leave a Reply

Your email address will not be published. Required fields are marked *